41137-87-5
41137-87-5 结构式
基本信息
Hirsutenone >=95% (LC/MS-ELSD)
(4E)-1,7-Bis(3,4-dihydroxyphenyl)-4-hepten-3-one
4-Hepten-3-one, 1,7-bis(3,4-dihydroxyphenyl)-, (4E)-
物理化学性质
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/08/19 | HY-N4042 | (4E)-1,7-双(3,4-二羟基苯基)-4-庚烯-3-酮 Hirsutenone | 41137-87-5 | 1 mg | 2450元 |
| 2023/03/20 | HY-N4042 | (4E)-1,7-双(3,4-二羟基苯基)-4-庚烯-3-酮 Hirsutenone | 41137-87-5 | 5 mg | 13000元 |
常见问题列表
Hirsutenone (0-100 μM; 48 hours) inhibits adipogenesis in 3T3-L1 preadipocytes and exhibits non-toxicity at 20-100 μM. Hirsutenone (0-100 μM; 48 hours) attenuates MDI-induced lipid accumulation in 3T3-L1 preadipocytes in a dose-dependent manner. In particular, HST at 40 and 80 μM significantly reduces MDI-induced adipogenesis in 3T3-L1 preadipocytes.Hirsutenone (0-100 μM; 48 hours) reduces the protein expression levels of PPARg, C/EBPa, and FAS in a dose-dependent manner in 3T3-L1 preadipocytes.Hirsutenone (80 μM; 20-24 hours) suppresses the cell cycle entry to S and G2/M phases occurrs at 20 hours when compares with at 20 hours. At 24 h, more cells are arrested in G1 phase (53% of total cells) when compares with the MDI-induced group which contains the majority of cells (56% of total cells) in G2/M phase.